Further analysis of cell surface CD24 protein levels validated our gene-wide gene expression analysis and revealed that 5-FU treatment enriched not only CD133+ but also CD24lo subsets of human colon carcinoma cells. The gene discussed is PROM1; the disease is colon carcinoma.